Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Does Hyaluronidase permit volume reduction in sub-Tenon anaesthesia?
2005-001203-19Phase 4Completed
- Sponsor
- Leeds Teaching Hospitals NHS Trust
- Start
- Aug 2005
- Modality
- Therapeutic Enzymes → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised, single-blind trial of hyaluronidase in cataract (2 arms), sponsored by Leeds Teaching Hospitals NHS Trust. Primary endpoints: Efficacy of sub-Tenon’s anaesthesia (eye movement) and Minimum Local Anaesthetic Volume (MLAV). Started Aug 2005; status: completed.
02
Drugs
hyaluronidase
03
Conditions
cataract
Beyond the preview
Go deeper on 2005-001203-19.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-001203-19.